Evidence map›Paper›PMID 41621017›Full record

ReviewAmino acids2026

Genetic commonalities between rare subtypes of ALS and CMT: insights into molecular mechanisms of neurodegeneration.

Abdilatif Aynaashe, Petri Kursula

Abstract readReview
In one paragraph

Review in Amino acids, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Abdilatif AynaasheDepartment of Biomedicine, University of Bergen, Bergen, Norway.
Petri KursulaDepartment of Biomedicine, University of Bergen, Bergen, Norway. petri.kursula@uib.no.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Amyotrophic lateral sclerosis (ALS) and Charcot-Marie-Tooth disease (CMT) are two distinct neurodegenerative disorders. While ALS is characterised by rapidly progressive motor neuron degeneration, leading to severe complications and death, CMT as a peripheral neuropathy is less severe, and patients have a longer life span, although with a compromised quality of life. Despite their clinical differences, current knowledge suggests that familial ALS (fALS) and CMT may share common genetic and molecular mechanisms. We aimed to identify shared genes mutations and molecular pathways between fALS and CMT through a literature and database search. Thirteen genes were identified, involved in distinct cellular processes: axonal transport (DYNC1H1, KIF5A, SPG11, DCTN1), protein homeostasis (NEFH, VCP, SOD1), RNA metabolism (GARS, SETX), cellular stress response (HSPB1, FIG4), and mitochondrial function (MFN2, CHCHD10). While these linkages to the two diseases are rare for each gene, understanding possible mechanistic commonalities at the molecular level can initiate new research directions, help in identifying additional common genes between neurodegenerative disorders, and improve diagnostics.

Indexed as

Amyotrophic Lateral SclerosisCharcot-Marie-Tooth DiseaseAxonal TransportDNA HelicasesDynactin ComplexFlavoproteinsHumansKinesinsMitochondriaMultifunctional EnzymesMutationPhosphoric Monoester HydrolasesProteinsRNA HelicasesSuperoxide Dismutase-1Valosin Containing ProteinDCTN1 protein, humanDNA HelicasesDynactin ComplexFIG4 protein, humanFlavoproteinsKIF5A protein, humanKinesinsMultifunctional EnzymesPhosphoric Monoester HydrolasesProteinsRNA HelicasesSETX protein, humanSOD1 protein, humanSPG11 protein, humanSuperoxide Dismutase-1Valosin Containing ProteinVCP protein, humanALSAxonal transport dysfunctionCMTMitochondrial dysfunctionMolecular mechanismNeurodegenerationProtein aggregationRNA transport and metabolismStress response dysfunction

Identifiers

PMID41621017
PMCPMC12881070

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.